Page last updated: 2024-08-18

pyrroles and Blood Loss, Surgical

pyrroles has been researched along with Blood Loss, Surgical in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hidaka, Y; Imai, T; Inaba, T; Kagawa, T; Omae, K; Tanaka, S1
Choi, G; Kang, H; Kim, BJ; Kim, JG1
Beltran, L; Bycroft, J; Green, JS; Hussain, M; Nair, R; Peters, JL; Powles, T; Shaw, GL1

Reviews

1 review(s) available for pyrroles and Blood Loss, Surgical

ArticleYear
Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
    Medicine, 2019, Volume: 98, Issue:24

    Topics: Blood Loss, Surgical; Endoscopic Mucosal Resection; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome; Ulcer

2019

Trials

1 trial(s) available for pyrroles and Blood Loss, Surgical

ArticleYear
Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: A cross-design synthesis of randomized and observational studies.
    PloS one, 2021, Volume: 16, Issue:12

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Cross-Sectional Studies; Endoscopic Mucosal Resection; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Pyrroles; Stomach Ulcer; Sulfonamides

2021

Other Studies

1 other study(ies) available for pyrroles and Blood Loss, Surgical

ArticleYear
Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
    Urologia internationalis, 2012, Volume: 89, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Blood Loss, Surgical; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Length of Stay; London; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Staging; Nephrectomy; Postoperative Complications; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Sunitinib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2012